Challenges and Opportunities in Dose Finding in Oncology and Immuno-oncology. [electronic resource]
- Clinical and translational science 07 2018
- 345-351 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
1752-8062
10.1111/cts.12540 doi
Antineoplastic Agents, Immunological--administration & dosage Clinical Trials, Phase II as Topic--standards Clinical Trials, Phase III as Topic--standards Dose-Response Relationship, Drug Drug Development--standards Humans Maximum Tolerated Dose Medical Oncology--standards Neoplasms--drug therapy United States United States Food and Drug Administration--standards